Vanguard Group’s Bellerophon Therapeutics, Inc. BLPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $58K | Hold |
|
|||||
|
2023
Q2 | $101K | Hold |
|
|||||
|
2023
Q1 | $1.15M | Hold |
|
|||||
|
2022
Q4 | $131K | Sell |
|
|||||
|
2022
Q3 | $376K | Sell |
|
|||||
|
2022
Q2 | $443K | Hold |
|
|||||
|
2022
Q1 | $852K | Sell |
|
|||||
|
2021
Q4 | $1.15M | Buy |
|
|||||
|
2021
Q3 | $1.39M | Buy |
|
|||||
|
2021
Q2 | $1.63M | Sell |
|
|||||
|
2021
Q1 | $1.86M | Sell |
|
|||||
|
2020
Q4 | $2.51M | Buy |
|
|||||
|
2020
Q3 | $3.6M | Sell |
|
|||||
|
2020
Q2 | $4.48M | Buy |
|
|||||
|
2020
Q1 | $832K | Buy |
|
|||||
|
2019
Q4 | $389K | Hold |
|
|||||
|
2019
Q3 | $536K | Sell |
|
|||||
|
2019
Q2 | $690K | Buy |
|
|||||
|
2019
Q1 | $649K | Buy |
|
|||||
|
2018
Q4 | $584K | Sell |
|
|||||
|
2018
Q3 | $1.1M | Buy |
|
|||||
|
2018
Q2 | $2.42M | Buy |
|
|||||
|
2018
Q1 | $2.04M | Buy |
|
|||||
|
2017
Q4 | $1.92M | Buy |
|
|||||
|
2017
Q3 | $870K | Hold |
|
|||||
|
2017
Q2 | $821K | Buy |
|
|||||
|
2017
Q1 | $598K | Buy |
|
|||||
|
2016
Q4 | $28K | Hold |
|
|||||
|
2016
Q3 | $75K | Sell |
|
|||||
|
2016
Q2 | $151K | Hold |
|
|||||
|
2016
Q1 | $215K | Hold |
|
|||||
|
2015
Q4 | $259K | Hold |
|
|||||
|
2015
Q3 | $454K | Buy |
|
|||||
|
2015
Q2 | $453K | Buy |
|